论文部分内容阅读
目的:研究巢蛋白(Nestin)和SOX2在皮肤恶性黑色素瘤中的表达及临床意义。方法:选取2010年1月-2013年1月我院收治的恶性黑色素瘤21例患者(研究组),另选黑色素痣患者21例(对照组),应用免疫组织化学法检测Nestin和SOX2,并比较两组Nestin和SOX2表达,分析其与患者生存期和转移的关系。结果:研究组Nestin和SOX2阳性表达率显著高于对照组,两组比较差异具有统计学意义(P<0.05);Nestin、SOX2阳性的恶性黑色素瘤患者生存期显著低于Nestin、SOX2阴性恶性黑色素瘤患者,两组比较差异有统计学意义(P<0.05),Nestin、SOX2阳性的恶性黑色素瘤患者与Nestin、SOX2阴性的恶性黑色素瘤患者转移率比较无统计学意义(P>0.05)。结论:Nestin和SOX2表达阳性与恶性黑色素有关,且与恶性黑色素瘤的生存期有关。。
Objective: To study the expression and clinical significance of Nestin and SOX2 in cutaneous malignant melanoma. Methods: 21 patients with malignant melanoma (study group) and 21 patients with melanotic nevus (control group) were selected from January 2010 to January 2013 in our hospital. Nestin and SOX2 were detected by immunohistochemistry Nestin and SOX2 expression in both groups were compared, and their relationship with survival and metastasis was analyzed. Results: The positive rates of Nestin and SOX2 in the study group were significantly higher than those in the control group (P <0.05). The survival rates of Nestin and SOX2-positive malignant melanoma patients were significantly lower than those of Nestin and SOX2-negative malignant melanocytes The difference between the two groups was statistically significant (P <0.05). There was no significant difference in the metastasis rate between Nestin and SOX2 positive malignant melanoma patients and Nestin and SOX2 negative malignant melanoma patients (P> 0.05). Conclusion: The positive expression of Nestin and SOX2 is associated with malignant melanin, which is related to the survival of malignant melanoma. .